论文信息 - CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide - 字舞流文

CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide

A. Valladares-Salgado | M. Cruz | O. Castelán-Martínez | E. Tesoro-Cruz | C. Hoyo‐Vadillo | T. B. Bazán-Soto | Osvaldo D. Castelán-Martínez | Carlos Hoyo-Vadillo | Miguel Cruz | Miguel Cruz